ACUTE ORAL CALCIUM-SODIUM CITRATE LOAD IN HEALTHY-MALES - EFFECTS ON ACID-BASE AND MINERAL METABOLISM, OXALATE AND OTHER RISK-FACTORS OF STONE FORMATION IN URINE
Po. Schwille et al., ACUTE ORAL CALCIUM-SODIUM CITRATE LOAD IN HEALTHY-MALES - EFFECTS ON ACID-BASE AND MINERAL METABOLISM, OXALATE AND OTHER RISK-FACTORS OF STONE FORMATION IN URINE, Methods and findings in experimental and clinical pharmacology, 19(6), 1997, pp. 417-427
The currently preferred calcium preparations for supplementation of fo
od vary widely with respect to calcium availability effects on systemi
c mineral metabolism, acid-base status, and the calciuria-induced risk
of urinary tract stone formation. In eight healthy males we studied t
he response to an acute load with alkali(sodium)-containing soluble ca
lcium citrate (CSC) (molar ratio calcium/sodium/citrate approx. = 1/1/
1), when taken in three different doses (10, 20, 30 mmol calcium) toge
ther with a continental breakfast. Intestinal calcium absorption, seru
m calcium, calcitonin, parathyroid hormone (PTH) other markers of bone
metabolism, net acid excretion and calcium oxalate crystallization in
urine were evaluated CSC evoked a dose-dependent increase in calcium
absorption, calcium in serum and urine, but no overt hypercalcemia and
calciuria was low relative to the excess calcium ingested; PTH fell a
nd calcitonin rose (p < 0.05 vs. breakfast alone), but the diet-indepe
ndent markers of bone resorption declined only insignificantly while t
he markers of bone formation and turnover remained unchanged. There wa
s a significant ''once-daily'' effect (= cumulative 24 h postload resp
onse) of CSC: a decrease in urinary cyclic AMP: phosphorus, and ammoni
um, and art increase in urinary bicarbonate. Soon after CSC intake, ur
inary calcium oxalate and hydroxyapatite supersaturation increased dos
e-dependently, the calcium oxalate crystal diameter was increased but
crystal aggregation time, which is crucial for stone formation, remain
ed statistically unchanged. Thus, CSC provides calcium in a bioavailab
le form, creates mild systemic alkalinisation and inhibition of bone r
esorption, but leaves the risk of developing urinary stones unchanged.
Comparative long-term studies on bone growth and the maintenance of b
one health, using alkali-containing versus alkali-free calcium citrate
, appear worthwhile.